Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
2.630
-0.060 (-2.23%)
At close: May 12, 2025, 4:00 PM
2.650
+0.020 (0.76%)
After-hours: May 12, 2025, 5:20 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $87.31 million as of May 12, 2025. Its market cap has decreased by -73.79% in one year.
Market Cap
87.31M
Enterprise Value
-3.12M
1-Year Change
-73.79%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $87.31M, a decrease of -67.83%. That is a compound annual growth rate of -52.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 89.30M | -58.97% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |